Cytotoxic T lymphocytes directed to the preferentially expressed antigen of melanoma (PRAME) target chronic myeloid leukemia.
Cytotoxic T lymphocytes directed to the preferentially expressed antigen of melanoma (PRAME) target chronic myeloid leukemia. Blood. 2008 Sep 01; 112(5):1876-85.
-
Antigen-Presenting Cells
-
Antigens, Neoplasm
-
Cell Line
-
Cell Line, Tumor
-
Cytotoxicity, Immunologic
-
HLA-A Antigens
-
HLA-A2 Antigen
-
Humans
-
Immunotherapy, Adoptive
-
Interferon-gamma
-
K562 Cells
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
-
RNA, Messenger
-
RNA, Neoplasm
-
T-Lymphocytes, Cytotoxic